GlyCLICK®: A Precise & Versatile Conjugation Platform for Improved ADCs

• Introducing GlyCLICK® as an enzyme-based platform for precise, site-specific antibody conjugation
• Enabling highly homogeneous ADCs with defined DARs while preserving antibody function
• Supporting controlled and scalable ADC generation across a broad range of antibody formats and payloads

Speakers:

Andreas Naegeli

Head of Business Development

Genovis